The IPO Buzz: Caris Life Sciences (CAI Proposed) Raises IPO Price Range to $19-$20
Caris Life Sciences, Inc. (CAI Proposed), an AI TechBio precision medicine pioneer focused on cancer, increased its IPO price range to $19.00 to $20.00 – up from its initial price range of $16.00 to $18.00 – and kept the number of shares at 23.53 million shares – to raise $458.84 million, if priced at $19.50, the […]
June 16, 2025 Read More